These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28116597)

  • 1. Pediatric Drug Development and Dosage Form Design.
    Preis M; Breitkreutz J
    AAPS PharmSciTech; 2017 Feb; 18(2):239-240. PubMed ID: 28116597
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems posed by the adjusting of a dosage form of a drug for children].
    Bernheim C
    Therapie; 1989; 44(2):145-50. PubMed ID: 2756521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical interactions in solid dosage forms.
    Narang AS; Desai D; Badawy S
    Pharm Res; 2012 Oct; 29(10):2635-8. PubMed ID: 22936283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chirality in new drug development. Clinical pharmacokinetic considerations.
    Nation RL
    Clin Pharmacokinet; 1994 Oct; 27(4):249-55. PubMed ID: 7834962
    [No Abstract]   [Full Text] [Related]  

  • 8. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
    Ticehurst MD; Marziano I
    J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues impacting therapeutic outcomes in pediatric patients: an overview.
    Kalra A; Goindi S
    Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Wish List for Drug Development in Pediatrics.
    Meyers R
    J Pharm Sci; 2020 Feb; 109(2):939-943. PubMed ID: 31676269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid form screening--a review.
    Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations].
    Antal I
    Acta Pharm Hung; 2006; 76(3):149-54. PubMed ID: 17094663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release dosage: recent advances and potential in pediatric medicine.
    Flament MP
    Ther Deliv; 2016; 7(4):197-9. PubMed ID: 27010982
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug delivery for optimised products: from product life-cycle management to first-generation product concepts.
    Bhatt PP
    Expert Opin Drug Deliv; 2005 Jan; 2(1):1-2. PubMed ID: 16296731
    [No Abstract]   [Full Text] [Related]  

  • 15. A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentals.
    Debotton N; Dahan A
    Drug Discov Today; 2014 Sep; 19(9):1322-36. PubMed ID: 24846709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric Drug Development and Formulation Design-a European Perspective.
    Van Riet-Nales DA; Kozarewicz P; Aylward B; de Vries R; Egberts TC; Rademaker CM; Schobben AF
    AAPS PharmSciTech; 2017 Feb; 18(2):241-249. PubMed ID: 27270905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between in vitro drug dissolution and in vivo response.
    Langguth P; Marroum P
    Biopharm Drug Dispos; 2012 Oct; 33(7):347-8. PubMed ID: 22910968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buccal Dosage Forms: General Considerations for Pediatric Patients.
    Montero-Padilla S; Velaga S; Morales JO
    AAPS PharmSciTech; 2017 Feb; 18(2):273-282. PubMed ID: 27301872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in the use of medications in the pediatric patient.
    Caselli MA
    J Am Podiatry Assoc; 1981 Feb; 71(2):54-9. PubMed ID: 7204849
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric Drug Formulations - Unintended Consequences of Legislation.
    Probst LA; Welch TR
    N Engl J Med; 2017 Feb; 376(8):795-796. PubMed ID: 28225679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.